학술논문
A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer
Document Type
Article
Author
Source
In Clinical Lung Cancer November 2021 22(6):531-540
Subject
Language
ISSN
1525-7304